Uniparts India: IPO Dates GMP Price

-

 There is a stir in the gray market regarding the IPO of Uniparts India. The company's stock is at a premium of Rs 65 in the gray market.

 Uniparts India IPO Open for Subscription: 

If you want to earn money by investing in the IPO market, then you have a good chance from today i.e. 30th November. The IPO of Uniparts India, a company providing engineering systems and solutions, has opened for subscription on 30 November. The company has fixed a price band of Rs 548-577 per share for the IPO. This IPO can be subscribed till 2 December. This IPO is completely based on Offer for Sale (OFS). The brokerage house has advised to subscribe considering the strong fundamentals of the company.
 

Subscribed Rating on IPO.

 Brokerage house Choice Broking has subscribed rating on Uniparts India IPO. The brokerage says that its valuation looks reasonable compared to peers. It is at 2.2 multiple of EV/sales at the higher price band. The company is on a profitable track and has better return ratios as compared to peers. Considering the global policies like major infrastructure capex plans by most of the major economies, it seems that the company has ample scope to expand its business at a higher rate. At the same time, it will also benefit from the improvement in mechanization in agriculture and the China Plus Strategy.
 

 What is the price in gray market?

There is a stir in the gray market regarding the IPO of Uniparts India. The company's stock is at a premium of Rs 65 in the gray market. If we look at the initial trend of gray market, its listing can be done with an increase of 11 percent in terms of upper price band of Rs.577.
 

 Uniparts India IPO: How much reserve for whom?

50% of Uniparts India's IPO is reserved for Qualified Institutional Buyers (QIB). While 15 percent is reserved for NII and 35 percent is reserved for retail investors. The lot size in this is of 25 shares. Maximum 13 lots can be bought.
 

 These promoters will sell their shares.

14,481,942 equity shares will be sold by way of OFS by the Promoter Group Entity and existing investors. Among the promoters, Karan Soni 2018 CG-NG Nevada Trust, Mehar Soni 2018 CG-NG Nevada Trust, Pamela Soni, Ashoka Investment Holdings and Ambadevi Mauritius Holding will reduce their shares. This IPO will be completely OFS, so the company will not get any income from the public issue.
 

 IPO launched in the third attempt.

Uniparts India's IPO has come in the third attempt. The company had earlier submitted IPO documents to SEBI in December 2018 and September 2014, for which it had also got approval but then the IPO could not come. Axis Capital, DAM Capital Advisors and JM Financial are the book running lead managers to the issue.
 

 what does the company do

Uniparts India is a global manufacturer of engineering systems and solutions. The company has its presence in 25 countries across the world. Uniparts is one of the leading suppliers of systems and components to the off-highway market in the agriculture and construction, forestry and mining and aftermarket sectors. The company's product portfolio includes the core product verticals of 3-point linkage systems and precision machined parts as well as the product verticals of power take-off, fabrication and hydraulic cylinders or parts thereof. 

Also read technical analysis of TCS Click here

Comments

Post a Comment

Popular posts from this blog

The Role of SEBI in Regulating the Indian Stock MarketIntroduction

-
The Role of SEBI in Regulating the Indian Stock MarketIntroduction: The Securities and Exchange Board of India (SEBI) plays a vital role in overseeing and regulating the Indian stock market. Established in 1988, SEBI is the regulatory authority tasked with ensuring fair and transparent functioning of India's capital markets. In this article, we will explore the key responsibilities and functions of SEBI and understand its significance in maintaining investor confidence and market integrity. 1. Regulatory Functions of SEBI: SEBI's primary objective is to protect the interests of investors and promote the development of the securities market. The regulatory functions of SEBI include: Registration and Regulation of Market Intermediaries:  SEBI registers and regulates various market participants, such as stockbrokers, depository participants, merchant bankers, and mutual funds. It sets guidelines and codes of conduct for their operations. Regulation of Stock Exchanges: SEBI oversee...
Read full article »

How to Start Trading in the Indian Stock Market

-
 A Beginner's Guide: How to Start Trading in the Indian Stock Market Introduction The Indian stock market offers a world of opportunities for investors looking to grow their wealth. However, diving into the market without proper knowledge can be overwhelming. If you're a newcomer, fear not! This article will guide you through the essential steps to start trading in the Indian stock market. Understanding the Indian Stock Market Before you start trading, it's crucial to grasp the basics of the Indian stock market. The market is primarily divided into two major exchanges: the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). Both exchanges facilitate the buying and selling of stocks, commodities, and derivatives. Getting Started: Open a Demat and Trading Account The first step towards stock market trading in India is to open a Demat and Trading account. A Demat account holds your securities in electronic form, while a Trading account allows you to buy and sell...
Read full article »

five analyst stock picks with over 10% revenue and profit growth in Q2FY23

-
Image
FIVE STOCK WITH 10% GROWTH This week, we take a look at five analyst stock picks with over 10% revenue and profit growth in Q2FY23 1.Solar Pharmaceutical Industries:   KRChoksey maintains its ‘purchase’ score on this pharmaceutical massive with a target charge of Rs 1,229– an upside of 19.9%. In Q2FY23, the agency’s net income grew 10.5% YoY to Rs 2,262.2 crore and revenue rose 13.8% YoY to Rs 10,952.3 crore.  Analyst Kushal Shah believes that the enterprise’s increase in Q2 was primarily pushed by using the worldwide distinctiveness business phase. In terms of geography, increase turned into led via america, India, and rising market segments, he brought. The analyst expects the organisation to retain to perform well within the US market at the back of recent launches, higher supply chain control, and market proportion profits. The company’s product pipeline in the US stays healthful with ninety two abbreviated new drug programs and thirteen new drug programs looking forward ...
Read full article »